Microenvironmental Interaction Between Hypoxia and Endothelial Cells Controls the Migration Ability of Placenta-Derived Mesenchymal Stem Cells via [alpha]4 Integrin and Rho Signaling

• Published in: Journal of cellular biochemistry 2016-05, Vol.117 (5), p.1145
• Main Authors: Choi, Jong Ho, Lim, Seung Mook, Yoo, Yong In, Jung, Jieun, Park, Jong-Won, Kim, Gi Jin
• Format: Article
• Language: English
• ISSN: 0730-2312; 1097-4644
• DOI: 10.1002/jcb.25398

Mesenchymal stem cells (MSCs) are a powerful source for cell therapy in degenerative diseases. The migration ability of MSCs is an important factor that enhances the therapeutic effect of the cells when they are transplanted into target tissues or organs. Hypoxia and the endothelial barrier, which are representative migration microenvironmental factors, are known to be regulated by the integrin-mediated pathway in several cancers. However, their regulatory mechanisms in MSCs remain unclear. Here, the objectives of the study were to compare the expression of markers related to integrin-mediated signaling in placenta-derived MSCs (PDMSCs) dependent on hypoxia and co-cultured with human umbilical vein endothelial cells (HUVECs) and to evaluate their correlations between migration ability and microenvironmetal factors including hypoxia and endothelial cells. The migration abilities of PDMSCs exposed to hypoxic conditions were significantly increased compared with normal fibroblasts (WI-38) and control (P